Priscila Sena-Pereira
Salem, BW 72076, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Association of rare apolipoprotein E ε4 homozygosity with an earlier age at onset in spinocerebellar ataxia type 3.
Journal: Human molecular genetics
Published: December 23, 2025
Proteostasis disruption and lipid dyshomeostasis in neurodegeneration: exploring common druggable targets across sporadic and monogenic disorders.
Journal: Frontiers in molecular neuroscience
Published: August 06, 2025
Loss-of-function variants in the CAPN1 activator CD99L2 cause X-linked spastic ataxia.
Journal: Nature communications
Published: March 31, 2025
The parkin V380L variant is a genetic modifier of Machado-Joseph disease with impact on mitophagy.
Journal: Acta neuropathologica
Published: February 26, 2024
Implications of specific lysine residues within ataxin-3 for the molecular pathogenesis of Machado-Joseph disease.
Journal: Frontiers in molecular neuroscience
Published: December 28, 2022
KPNB1 modulates the Machado-Joseph disease protein ataxin-3 through activation of the mitochondrial protease CLPP.
Journal: Cellular and molecular life sciences : CMLS
Published: December 20, 2021
Pathophysiological interplay between O-GlcNAc transferase and the Machado-Joseph disease protein ataxin-3.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 28, 2021
Calpains as novel players in the molecular pathogenesis of spinocerebellar ataxia type 17.
Journal: Cellular and molecular life sciences : CMLS
Published: August 09, 2021
Neurodegenerative phosphoprotein signaling landscape in models of SCA3.
Journal: Molecular brain
Published: September 22, 2020
Killing Two Angry Birds with One Stone: Autophagy Activation by Inhibiting Calpains in Neurodegenerative Diseases and Beyond.
Journal: BioMed research international
Published: October 31, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026